Inhaler technique is it important?. Compton et al (2006) Review of evidence from 6 European countries ( Spain, Italy, France, Germany, Netherlands, UK)

Slides:



Advertisements
Similar presentations
Depression in adults with a chronic physical health problem
Advertisements

National ReUse Conference 2009 Atlanta, GA Presented by Chris Brand President/CEO Friends of Disabled Adults and Children, Too!
Asthma Medication Administration Marcia Winston, MSN,CPNP,AE-C The Children’s Hospital of Philadelphia Division of Pulmonary Medicine.
Steps to better asthma care A guide for primary care.
Successful Solutions Professional Development LLC Chapter 3 Medication Management.
Respiratory Prescribing in Tower Hamlets Bill Sandhu Head of Medicines Management, Tower Hamlets Medicines Management Team.
The Least Imperfect Device Karen Meade Clinical Nurse Specialist The Hillingdon Hospital.
Respiratory Measurement and Treatment Gail M. Maier, Ph.D., R.N. Associate Director, ED&R The Ohio State University Wexner Medical Center Peak Flow and.
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Managing asthma & Inhaler devices for respiratory disease.
Perform and therapeutic benefit of Using a Nebuliser / Inhaler correctly Devangna Bhatia.
1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.
Paediatric Asthma Maria Tracey Paediatric Pharmacist Jane Davis Paediatric Clinical Nurse Specialist CF/Respiratory Royal Alexandra Hospital Paisley.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
Karen Homan NHS Bedfordshire
Plymouth Health Community NICE Guidance Implementation Group Asthma inhalers for routine treatment of chronic asthma in older children (aged years)
London Respiratory Team Understanding respiratory spend and increasing value: Inhalers and nicotine replacement therapy Responsible Respiratory Prescribing.
MANAGEMENT OF ASTHMA 6 Penaflor, Dominic Quinto, Milraam Ramos,Josefa Victoria Sicat, Gracie Suaco, David Tio- Cuizon, Jeremiah Valenzuela, Virginia Lou.
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 3 Administration of Aerosolized Agents.
1 Asthma October 30, Weiss, Gergen, & Hodgson (1992)2 Pediatric Statistics Prevalence increasing School absences Estimated as more than 10 million.
What makes difficult asthma difficult? SCH Journal Club Nicki Barker 2012 June 2012 Dysfunctional breathing in children1.
David P. Arpino, RRT, RPFT ALHE 4060 – Research in Allied Health Dr. Masini August 2, 2007.
BACLOFEN AS AN ADJUNCT PHARMACOTHERAPY FOR THE MAINTENANCE OF ABSTINENCE IN ALCOHOL DEPENDENT PATIENTS WITH ESTABLISHED LIVER DISEASE Lynn Owens 1, Abi.
Self Care Instructions Exercise regularly Monitor your blood pressure Eat a healthful diet.
Asthma Medication and Devices Update Lisa C. Johnson RRT, RCP, BAS, AE-C Pediatric Asthma Program Vidant Medical Center.
Responsible Respiratory Prescribing
P RACTICAL ISSUES IN L ONG T REM M ANAGEMENT OF A STHMA DESPITE REGULAR FOLLOW UP Dr kondekar Santosh TN Medical college Mumbai
Component 4 Medications. Key Points - Medications  2 general classes: – Long-term control medications – Quick-Relief medications  Controller medications:
Asthma Guidelines, Diagnosis and Management Alison Hughes Respiratory Specialist Nurse Solent NHS Trust.
Wendy Pigg Practice support Pharmacist/Independent Prescriber
Areas to cover Analysis of information Recruitment Review.
Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Medicines Management Workstream Dr.
YOUR PHARMACY / JOB- TITLE YOUR NAME Respiratory MUR.
PICH Childhood Asthma project Bina Chauhan Locum GP 4/5/16.
Quick Fixes for Poor Asthma Control Barbara Carroll Langham RN,BSN Pediatric Asthma Care Manager Kaiser Permanente.
Fit and Well to Care Aids to Good Practice Eat Well and keep hydrated Keep Physically Active Care for Yourself Get Involved and Make a Contribution Take.
Medicines Optimisation
Jessica Case study.
Treating Mild Asthma: what’s in it for the patient? Regien Kievits,
MODERATE & ACUTE SEVERE ASTHMA
European-Comparative Effectiveness Research on online Depression Treatment E-COMPARED is funded by the European Community’s Seventh Framework.
Adult Asthma Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.
Child Asthma Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.
Medical care and self-management support for asthma in primary care: a comparison between France and the United Kingdom A.Dima, E. van Ganse, H. Le Cloarec,
Monitoring asthma in primary care
Patterns of asthma medications prescriptions among adult patients in the chest and accident and emergency units of a tertiary health care facility in Uganda.
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Improving Inhaler Technique
Management of Mild to Moderate Asthma
Medicines Optimisation
Asthma Annual Reviews Hetal Dhruve Presented by Anh Vu
The Modern Management of Asthma: Getting it right Part 2
Asthma Friendly Schools ASSEMBLY FOR SECONDARY
  Is school based directly observed therapy (DOT) in asthma always effective? (The Good, the Bad and the Ugly of DOT). Author: S Frost, J Bennett, T Evans,
Is school based DOT always effective. “The good, the bad and the Ugly
Compliance With NICE Guidelines for Children At Risk of Anaphylaxis In a Tertiary Allergy Centre Thaventhiran, P and Benjamin, L Children’s Allergy Service.
The Aerosol Drug Management Improvement Team
AEROSOL THERAPY.
Chapter 27 Pediatrics.
Childhood Asthma : Lessons still to be learnt
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Risk of bias summary for Cochrane review comparing pMDI and spacer to nebulisers to deliver β2-agonists to adults and children with acute asthma. Risk.
Chaney et al.’s funhaler study (2004)
The Aerosol Drug Management Improvement Team
The Aerosol Drug Management Improvement Team
The Aerosol Drug Management Improvement Team
The Aerosol Drug Management Improvement Team
Asthma Education for Families and HCPs
The Aerosol Drug Management Improvement Team
Baseline characteristics of people who inject drugs enrolled in the Montreal Hepatitis C Cohort (2004–2017), by prescribed dosage of opioid agonist treatment,
Presentation transcript:

Inhaler technique is it important?

Compton et al (2006) Review of evidence from 6 European countries ( Spain, Italy, France, Germany, Netherlands, UK) found  Up to 50% of patients are unable to take their inhaler correctly  Up to 40% of children make errors even with a spacer

BTS/SIGN 2011  Proportion of patients making no mistake with their inhaler MDI 23-43% MDI 23-43% DPI 53-59% DPI 53-59% MDI and spacer 55-57%

BTS/SIGN 2011  Teaching inhaler technique however improved the score  MDI from 23-43% to 63%  DPI from 55-57% to 75%

BTS/SIGN 2011 Recommend Prescribe inhalers only after patients have received training in the use of the device And have demonstrated a satisfactory technique

BTS/SIGN Guidelines 2012 In stable asthma (B2 agonists) In stable asthma (B2 agonists)  Children aged 5-12 pMDI & Spacer are as effective as any other inhaler  In adults pMDI & Spacer are as effective as any other hand held inhaler but patients may prefer some types of DPI

NICE guidelines on inhalers in children (2002) Tell us the importance of ensuring the child is able to use the device effectively and consider the portability of the device

BTS/SIGN Guidelines 2012 Inhaled steroids in stable asthma Inhaled steroids in stable asthma  Children aged 5-12 pMDI & Spacer is as effective as any DPI  In adults pMDI & Spacer is as effective as any DPI

BTS/SIGN 2011 Children under 5  MDI and spacer  And in under 2 use MDI spacer and face mask

BTS/SIGN 2011 Care of spacers  Spacer should be compatible with the inhaler  Administer in single actuations  Minimal delay between actuation and inhalation  Tidal breathing is as effective as single breaths  Spacers should be cleaned monthly rather than weekly ( manufacturers recommendation ) as this reduces the effectiveness  Should be washed in detergent not rinsed and allowed to air dry

BTS/SIGN 2011  Adolescents with asthma prescribed MDI and spacer do not use the spacer as they feel they are too inconvenient  Adolescents inhaler choice should be considered to improve adherence to treatment

BTS/SIGN 2011  The choice of drug may be determined by the choice of drug  If the patient is unable to use the device satisfactorily an alternative should be found  The patients ability to use their inhaler should be assessed by a competent health care professional  The medication needs to be titrated against clinical response to ensure optimum efficacy  Reassess inhaler technique as part of a structured clinical review

GINA 2009  Poorly controlled asthma is expensive  Ensuring adequate effective preventer medication will give cost savings

Therefore

The cheapest inhaler is one the patient can and will take